Skip to main content
. Author manuscript; available in PMC: 2014 Aug 15.
Published in final edited form as: Immunity. 2013 Aug 22;39(2):259–271. doi: 10.1016/j.immuni.2013.05.018

Figure 1. Ubiquitination Modulates Treg Cell Function.

Figure 1

(A) Sorted human CD4+CD25highCD127low Treg cells were pretreated with 10 μM DUBi for 1 hr, washed, and cocultured with CFSE-labeled PBMCs in anti-CD3-coated wells for 4 days. CFSE dilution of CD4+ cells was analyzed by flow cytometry.

(B) CD4+CD45RBhigh cells were injected into immunodeficient mice. Sorted GFP+ Treg cells from Foxp3-GFP promoter mice were pre-incubated with 10 μM DUBi for 1 hr and injected 3 weeks later. Mice were sacrificed 3 weeks after Treg cell administration. Sections of the colon were analyzed and scored (five mice per group).

(C) Representative hematoxylin- and eosin-stained tissue slides of the colon.

(D) Analysis of CD4+GFP+ cell numbers in the spleen.

(E) Percentage of Foxp3+ CD4+ T cells in the spleen. Data shown are representative of at least three independent experiments, *p<0.05.

Data are represented as mean + SEM. See also Figure S1.